secwatch.observer — SEC 8-K summary
======================================

Issuer:     Wellgistics Health, Inc. (WGRX)
CIK:        0002030763
Form:       8-K
Filed at:   2026-10-20T13:24:21+00:00
Accession:  0001493152-26-047711
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

DataMeds AI regains Nasdaq $2.5M stockholders' equity compliance after April delisting notice
--------------------------------------------------------------------------------

- Nasdaq Staff notice dated Oct. 19, 2026 confirms DataMeds AI is back in compliance with Listing Rule 5550(b)(1), which requires $2.5M minimum stockholders' equity.
- The April 13, 2026 delisting notice cited stockholders' equity of $(12,447,801) at Dec. 31, 2025 and a separate failure to meet the $1.00 minimum bid price.
- Bid-price compliance was regained June 9, 2026; equity cure was evidenced in Form 8-K filings on Oct. 13 and Oct. 16, 2026 showing equity above $2.5M.
- Company cautions that failing to evidence compliance in its next periodic report could again subject MEDS to delisting proceedings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030763/000149315226047711/0001493152-26-047711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030763/000149315226047711/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-047711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer